LUGPA VL

A Residents Perspective on A Career in Urology and Navigating the Interview Process - Eric Ballon-Landa

Details
Eric Ballon-Landa joins Gordon Brown at the first Rising Chief Residents Summit, a Large Urology Group Practice Association (LUGPA) organized meeting. The Rising Chief Resident Summit aims to support post-graduate year 4 and 5 residents during their transition to full-time practice. In this video discussion, Dr. Ballon-Landa shares why he chose to pursue urology. He shares advice on the interview...

Choosing Urology as a Career Path - Gordon Brown

Details
Four Rising Chief Residents join Gordon Brown at the 2019 Rising Chief Resident Summit in short discussion offering their personal take on what drove them to decide on urology as a career path and deciding on surgery versus medicine. They share some of the decisions they weighed in making these choices and valuable insights for those in the position today, that are looking at that choice in front...

Overcoming Hurdles for Soon-To-Be Practitioners, The Rising Chief Resident Summit - Tom Stringer

Details
Tom Stringer joins Neal Shore to share highlights of his presentation at the first Rising Chief Residents Summit put together by the Large Urology Group Practice Association. This summit aims to support post-graduate year 4 and 5 residents during their transition to full-time practice. Dr. Stringer presented on crucial topics including vetting employment contracts, pursuing a career in academia, h...

Supporting Improved Patient Care Through Advanced Prostate Cancer Clinics - Gordon Brown

Details
Neal Shore and Gordon Brown discuss the advanced prostate cancer clinics in large urology group practices (LUGPA). Gordon provides insight into supporting patient care within the urology practice as they scale the advanced prostate cancer clinic into a GU oncology care model. The advanced prostate cancer clinic is a clinical pathway and guidelines driven with physician champions using the NCCN and...

BCG Shortage 2019: Managing Through Treatment and Reimbursement Issues - Neal Shore, Ashish Kamat, and Jonathan Rubenstein

Details
Neal Shore discusses the current 2019 shortage of BCG with Ashish Kamat and Jonathan Rubenstein. Bacillus Calmette-Guérin (BCG) is used as first-line intravesical therapy following tumor resection of non–muscle-invasive bladder cancer. Bacille Calmette-Guérin (BCG) has been a standard of care for many patients with non-muscle invasive bladder cancer for decades.Merck & Co., Inc., has advised that...

ProVent Trial for Newly Diagnosed Prostate Cancer - Benjamin Lowentritt

Details
Benjamin Lowentritt and Alicia Morgans discuss the ProVent trial, the use of sipuleucel-T in newly diagnosed prostate cancer patients on active surveillance. They discuss inclusion criteria, trial design and primary outcome measures which include assessing the efficacy of sipuleucel-T in reducing reclassification to a higher Gleason grade in patients on active surveillance. Biographies: Alicia Mor...

Evolution of Technology and Technique in Bladder Cancer - Ashish Kamat

Details
(Length of Discussion: 10 min) Ashish Kamat and Alicia Morgans discuss the highlights of his presentation at LUGPA 2018, on the evolution of technology and technique when treating bladder cancer. The initial resection of the bladder is paramount to the path of management for these patients, including the type of anesthesia, angles of scopes, white light and blue light detection, narrow-band imagin...

Focal Therapy: Ready or Not - Herbert Lepor

Details
(Length of Discussion: 20 min) Herb Lepor presents the current optimal management of localized prostate cancer including an in-depth review of focal ablation. He highlights technique, criteria for appropriate patient selection, and the value of counseling to managing expectations. Biography: Herbert Lepor, MD, Professor, Department of Urology, Professor, Department of Biochemistry and Molecular Ph...

Minimally Invasive Approaches in the Treatment of BPH: Ready to Replace TURP? - Claus Roehrborn

Details
Claus Roehrborn provides a state of the art review on contemporary management of male lower urinary tract symptoms and BPH. Biography: Claus Roehrborn, MD is at the Harold C. Simmons Comprehensive Cancer Center. Dr. Roehrborn is the S.T. Harris Family Chair in Medical Science, in Honor of John D. McConnell, M.D. and the E.E. Fogelson and Greer Garson Fogelson Distinguished Chair in Urology. A worl...

Immuno-Oncology in Bladder Cancer: The Urologist's Role - Noah Hahn

Details
In this lecture, Noah Hahn presents the importance of immuno-oncology (IO) - checkpoint inhibitors. Patients with urothelial carcinoma are receiving approved immuno-oncologic drugs that significantly extend survival and are safer and more tolerable than chemotherapy. The efficacy of immuno-oncologic agents in advanced urothelial cancer has naturally raised questions about their potential use in ea...
E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe